drugset / Trial / NCT02641938

Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury

NCT02641938 ↗

Phase 4 Completed 38 enrolled Gangnam Severance Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

To investigate the renal protective effect of dexmedetomidine in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy

Timeline

Start
2015-12
Primary completion
2017-11
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications